COMMONWEALTH EQUITY SERVICES, LLC
Position in MIRA — Mira Pharmaceuticals, Inc.
CIK 312272
WALTHAM, MA
Position in MIRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$50,369
+$12,848 QoQ
Shares Held
53,189
+51.7% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 26 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,480,387,003 across 17 Drug Manufacturers - General names. MIRA ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
344,848 | $413,621,071 | |
| 2 | JNJ |
Johnson & Johnson
|
1,249,344 | $317,295,895 | |
| 3 | ABBV |
AbbVie Inc.
|
975,105 | $245,375,422 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,149,713 | $147,738,120 | |
| 5 | AMGN |
Amgen Inc
|
309,478 | $112,068,173 | |
| 6 | PFE |
Pfizer Inc
|
3,277,599 | $78,924,583 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
975,574 | $56,212,573 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
246,685 | $31,166,182 |
All Filings in MIRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,369 | 53,189 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $37,521 | 35,067 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $45,582 | 30,187 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $41,054 | 30,187 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $35,893 | 29,664 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $25,036 | 25,547 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $17,182 | 15,072 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||